Navigation Links
Trubion Pharmaceuticals to Present at Fall 2008 Morgan Stanley Global Healthcare Unplugged Conference in New York
Date:8/27/2008

SEATTLE, Aug. 27 /PRNewswire-FirstCall/ -- Trubion Pharmaceuticals Inc. (Nasdaq: TRBN) today announced that executives will present a corporate update at the upcoming Morgan Stanley Global Healthcare Unplugged Conference to be held at the Grand Hyatt New York on Sept. 9, 2008. Dr. Peter Thompson, president, chief executive officer and chairman, and Dr. Scott C. Stromatt, newly appointed senior vice president and chief medical officer, are scheduled to present on Tuesday, Sept. 9 at 4:30 p.m. EDT. The presentation will be available via audio webcast on Trubion's investor website at investors.trubion.com.

About Trubion

Trubion is a biopharmaceutical company that is creating a pipeline of novel protein therapeutic product candidates to treat autoimmune and inflammatory diseases and cancer. The company's mission is to develop a variety of first-in-class and best-in-class product candidates, customized for optimal safety, efficacy and convenience that it believes may offer improved patient experiences. Trubion's current product candidates are novel single-chain protein, or SMIP(TM), therapeutics, and are designed using its custom drug assembly technology. Trubion's product pipeline includes CD20-directed candidates such as TRU-015 and SBI-087 for autoimmune and inflammatory diseases, developed under the company's Wyeth collaboration. Trubion's product pipeline also includes Trubion's proprietary product candidate, TRU-016, a novel CD37-targeted therapy for the treatment of B-cell malignancies that is currently in Phase 1/2 clinical evaluation. In addition to Trubion's current product candidates, the company is also developing additional alliance and proprietary product candidates that build on its product development experience.
'/>"/>

SOURCE Trubion Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Trubion Pharmaceuticals to Present at Upcoming Investor Conferences
2. Trubion Pharmaceuticals Announces Upcoming Presentations at American College of Rheumatology Annual Scientific Meeting
3. Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2007 Financial Results
4. Trubion Pharmaceuticals to Present at the Lazard Capital Markets Healthcare Investor Conference
5. Trubion Pharmaceuticals Inc. Reports Fourth-Quarter and Year-Ended 2007 Financial Results and Provides 2008 Financial Outlook
6. Trubion Announces Presentations at April/May Investor Conferences
7. Trubion Pharmaceuticals to Present at the 7th Annual Needham & Company Biotechnology & Medical Technology Conference
8. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
9. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
10. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
11. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ewswire/ -- Biotech firm Replikins Ltd., which has...18 pandemic through the prediction, outbreak, and ...d its latest biochemical analysis of the virus. Th...Swine Flu") virus has dropped from its peak of 3.7... the spring of 2009 to resting non-epidemic levels...
(Date:11/25/2009)...RNewswire/ -- Reportlinker.com announces that a ne...ogue: ,, Brazil Bioethanol Market Analysis and....com/p0165503/Brazil-Bioethanol-Market-Analysis-an...Market Analysis and Forecasts to 2013 ,, Summa...d forecasts of the global bioethanol market and th...
(Date:11/24/2009)... investment bank KTA Capital,s client Neuren Pharm...convertible note private placement with a U.S. ins...anged by KTA Capital as Neuren,s exclusive placeme...ew York (PRWEB) November 23, 2009 -- The independe...t;KTA Capital") has announced that its client...
(Date:11/24/2009)... employment grew by 29,000 jobs in October, and t...rowth during the U.S. recession. However, clinics ...lth systems are coming closer to having to actuall...ators. , (Vocus) November...ing in October despite the shedding of jobs in mos...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4
...1 DOR BioPharma, Inc. (OTC Bulletin Board: DORB) ...al company, today announced its financial results ...ximately $2.3 million compared to $1.3 million in ...with DOR,s September 2006 NIH grant and the result...t milestones with our subcontractors. , , DOR,s ...
... RSCI,s Chairman expressed his concern that since ...y for medical treatments, America needs to put mor...eatments to alleviate the suffering of millions di... Bangkok, Thailand (PRWEB) Ma...,s first stem cell treatment company and chairman ...
...rcell,s first marketed product, a new vaccine agai...ry personnel , , - Commercial product launch in ... Intercell AG (VSE: ICLL) today announced that th... IXIARO(R), a new vaccine for the prevention of Ja...se of Intercell,s vaccine - the only such product ...
Other Biology Technology:DOR BioPharma Reports Year-End 2008 Financial Results and Reviews Recent Accomplishments 2DOR BioPharma Reports Year-End 2008 Financial Results and Reviews Recent Accomplishments 3DOR BioPharma Reports Year-End 2008 Financial Results and Reviews Recent Accomplishments 4DOR BioPharma Reports Year-End 2008 Financial Results and Reviews Recent Accomplishments 5Repair Stem Cell Institute Warns About Real Cost of Embryonic Stem Cell Research 2Repair Stem Cell Institute Warns About Real Cost of Embryonic Stem Cell Research 3Intercell Announces FDA Approval of IXIARO(R), a Novel Vaccine to Prevent Japanese Encephalitis 2Intercell Announces FDA Approval of IXIARO(R), a Novel Vaccine to Prevent Japanese Encephalitis 3Intercell Announces FDA Approval of IXIARO(R), a Novel Vaccine to Prevent Japanese Encephalitis 4
(Date:11/24/2009)... and the American College of Medical Toxicology (A...e publication of the Journal of Medical Toxicolog...ing in March 2010. It was previously published by...ournal of Medical Toxicology , an international, p...e science and practice of medical toxicology. The...
(Date:11/24/2009)...lease is available in Spanish . , The prese...vels of inflammatory substances in the blood, hind...own by a research project of the University of Nav...ntist at the School of Pharmacy. , The project, ... relation to the control of body weight and inflam...
(Date:11/23/2009)...study by the Wildlife Conservation Society says th...p in the Republic of Congopart of the "mother lode...arare becoming increasingly threatened by growing ...mends protection of the swamp forests adjacent to ...fter recent surveys confirmed that high densities ...
Breaking Biology News(10 mins):Springer and the American College of Medical Toxicology to work together 2It can be predicted the reaction obese patients will have to a diet 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Repligen to Present at the Rodman 26 Renshaw 11th Annual Healthcare Conference Wednesday September 9th 2 3A25 p m EDT 13791 1Repligen to Present at the Rodman 26 Renshaw 11th Annual Healthcare Conference Wednesday September 9th 2 3A25 p m EDT 13791 2Repligen to Present at the Rodman 26 Renshaw 11th Annual Healthcare Conference Wednesday September 9th 2 3A25 p m EDT 13791 3Jiangbo Pharmaceuticals to Present at Rodman 26 Renshaw Annual Global Investment Conference 13788 1Jiangbo Pharmaceuticals to Present at Rodman 26 Renshaw Annual Global Investment Conference 13788 2Jiangbo Pharmaceuticals to Present at Rodman 26 Renshaw Annual Global Investment Conference 13788 3Danaher to Acquire Life Sciences Instrumentation Businesses From MDS Inc and Life Technologies Corporation 55977 1Danaher to Acquire Life Sciences Instrumentation Businesses From MDS Inc and Life Technologies Corporation 55977 2Danaher to Acquire Life Sciences Instrumentation Businesses From MDS Inc and Life Technologies Corporation 55977 3Danaher to Acquire Life Sciences Instrumentation Businesses From MDS Inc and Life Technologies Corporation 55977 4
...ovember 2008 - Today, the European Molecular Biolo...12 of Europe,s most talented young researchers as ...Programme. , Now in its ninth year, the programme...ing European young researchers at a critical stage...receive a range of benefits designed to smooth the...
...ed study published October 29 in the online, open-...chlaug and Ellen Winner has found that children wh...ars outperform children with no instrumental train...d finger dexterity (skills honed by the study of a...verbal ability and visual pattern completion (skil...
... researcher Robin Gremaud has shown that an alloy ...cellent at absorbing hydrogen. This light alloy br...gen as a source of fuel for powering vehicles. A h...ive weight that is sixty percent less than a batte...eveloped a method which enabled simultaneous testi...
Other Biology News:12 outstanding young scientists named as EMBO Young Investigators 2Research shows that time invested in practicing pays off for young musicians 2Hydrogen tank lighter than battery 2
iEMS Incubator/Shaker 3 module from Thermo Scientific
Nepehloskan Ascent w/ 1st dispenser from Thermo Scientific
...lus USBio Analyzed PRODUCT SPECIFICATIONS Form: Wh...ntity (A,B): Passes tests pH (10 units/ml): 4.5 to...pper (Cu): less than or equal to 0.1% Bleomycin Co...reater than or equal to 90% B 4 : less than or equ...
...tical performance for all vacuum requirements. A 3...rmance to suit all applications. The large, sidevi...roper oil levels at a glance. The VLP series of pu...edVac concentrating and freeze drying systems for ...
Biology Products: